APA (7th ed.) Citation

F, U., I, Y., E, G., M, A., R, T., N, S., . . . C, O. (2025). Exenatide, a glucagon-like peptide-1 receptor agonist, may negatively impact bone healing in rats: Histopathological, biochemical, and in silico findings. Journal of orthopaedic surgery and research, 20(1), 883. https://doi.org/10.1186/s13018-025-06300-2

Chicago Style (17th ed.) Citation

F, Ugur, Yilmaz I, Guner E, Albayrak M, Taskin R, Sarikas N, Bildirici MA, Dellalbasi AB, and Ozcan C. "Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, May Negatively Impact Bone Healing in Rats: Histopathological, Biochemical, and in Silico Findings." Journal of Orthopaedic Surgery and Research 20, no. 1 (2025): 883. https://doi.org/10.1186/s13018-025-06300-2.

MLA (9th ed.) Citation

F, Ugur, et al. "Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, May Negatively Impact Bone Healing in Rats: Histopathological, Biochemical, and in Silico Findings." Journal of Orthopaedic Surgery and Research, vol. 20, no. 1, 2025, p. 883, https://doi.org/10.1186/s13018-025-06300-2.